Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration
Microglia, the resident immune cells of the central nervous system (CNS), play an important role in CNS homeostasis during development, adulthood and ageing. Their phenotype and function have been widely studied, but most studies have focused on their local interactions in the CNS. Microglia are derived from a particular developmental niche, are long-lived, locally replaced and form a significant part of the communication route between the peripheral immune system and the CNS; all these components of microglia biology contribute to maintaining homeostasis. Microglia function is tightly regulated by the CNS microenvironment, and increasing evidence suggests that disturbances, such as neurodegeneration and ageing, can have profound consequences for microglial phenotype and function. We describe the possible biological mechanisms underlying the altered threshold for microglial activation, also known as ‘microglial priming’, seen in CNS disease and ageing and consider how priming may contribute to turning immune-to-brain communication from a homeostatic pathway into a maladaptive response that contributes to symptoms and progression of diseases of the CNS.
KeywordsMicroglia Neurodegeneration Priming Systemic inflammation
The concept that the central nervous system (CNS) is an immunologically privileged organ has had a profound impact on the study of immune-to-brain interactions. Even though it is now well recognized that this immune privilege is only partial , for many neuroscientists, the nervous system is still perceived to be isolated from the immune system, with its components playing little or no role in the neural networks and communicating pathways. It is also the case that for many immunologists, the CNS is a foreign land. It is clear that the interaction between the nervous and immune systems is a two-way communication, each having a profound influence on the other. These influences extend from homeostasis to pathology, with the immune system acting as a major transducer of both internal and external environmental challenges to the host. Involvement of the immune system can arise from CNS resident innate immune cells or from cellular and soluble factors from the periphery that act on the CNS via neural or humoural routes. The heterogeneity of the macrophage populations in the CNS is reflected in the differential responses in different tissue compartments each playing distinct roles in homeostasis and pathology.
Microglia in the developing brain
The notion that the microglia are the resident macrophages of the CNS is well accepted, but precisely from where they originate and when they populate the tissue has been a matter of much debate . Microglia are long-lived cells, and studies in mouse have suggested that they are predominantly maintained via self-renewal under steady-state conditions . The recent study of Ginhoux and colleagues provides good evidence in mouse that a significant proportion of these cells arise from the yolk sac and populate the neuroepithelium in early (before E10.5) embryogenesis . However, what is less clear is whether, and to what extent, there is a contribution from a bone marrow myeloid progenitor at later stages of embryonic development or in the postnatal period. Pioneering work by Rio Hortega in the early 1900s and subsequent studies showed that the microglia appear to invade the developing brain from the vasculature at a time when bone marrow hematopoiesis is ongoing [5, 6]. Ginhoux et al.  report that only a proportion of the cells were labelled by the genetic manipulation that defined them as of yolk sac origin, which was attributed to the inefficiency of Cre activation by the Runx promotor. While these studies have provided essential insight into the developmental origins of microglia, the potential contribution of non-yolk sac origin macrophages throughout the entire life course and after repeated immune challenges remains to be resolved.
The yolk-sac-derived macrophages that invade the primitive nervous system, the neuroepithelium, from the early vasculature have a typical macrophage morphology and phenotype, characterized by high expression of F4/80 and CD11b. As the neural tissue matures, there is widespread apoptotic cell death of both neurons and glia, and the embryonic and postnatal microglia are involved in the phagocytosis of these apoptotic bodies, implying that embryonic microglia are involved in determining the circuitry of the developing CNS . It has been proposed that microglia may actively kill some neurons during the period of cell death, but to date, this has only been convincingly demonstrated in vitro . The role of microglia in sculpting nervous system circuitry during this period of development, when there is exuberant axonal and synaptic connectivity, is a subject of much interest. In mice lacking components of the complement cascade, there is an excess convergence of connections from the retinal ganglion cells of the eye onto neurons in the dorsal lateral geniculate nucleus (dLGN) of the thalamus that is maintained until later in development than normal [8, 9]. It is proposed that complement component C1q decorates synapses that are destined to degenerate and then microglia recognize and remove these opsonized synapses [8, 9]. The notion that microglia are actively involved in the removal of synapses from their postsynaptic targets has a long history, and it was first invoked as a response by microglia in the removal of synapses from damaged or injured neurons, so-called synaptic stripping. As reviewed elsewhere , the evidence that microglia are active participants in synaptic stripping is unclear, and direct evidence that microglia recognize healthy synapses and select those which are about to lose the competition for a postsynaptic connection remains unproven. In contrast to the visual system, studies on the hippocampus of CX3C-receptor (CX3CR)-null mice describe the microglia as phagocytosing material derived from the postsynaptic density of the dendritic spine, the protein PSD-95 , rather than the pre-synaptic elements as described in the visual system. Although it was suggested that this form of synaptic pruning by microglia was necessary for normal development, the number of spines was only transiently different from normal at 15 days postnatal and by 40 days postnatal had achieved normal levels.
If the microglia are exclusively derived from the yolk sac during development, the interesting question is raised as to how the population is subsequently maintained during life: what are the relative contributions of local proliferation and recruitment from the blood, and are these pathways similar under healthy and diseased conditions? Lawson et al. , using tritiated thymidine with immunocytochemistry, demonstrated that microglia, under physiological conditions, proliferate more slowly than other tissue macrophage populations and are maintained in large part by local proliferation. To study the degree of recruitment from the blood, a number of laboratories have used bone marrow chimeras (BM-chimeras) with protein polymorphisms, genetic labels, Y-chromosome or more recently GFP to identify the donor cells [12, 13]. However, these studies have been shown to suffer from a serious artefact as a consequence of the irradiation strategy . Evidence from parabiotic animals  or following the generation of BM-chimeras with a head-shield to prevent conditioning of the CNS by the radiation [13, 16] showed very little evidence of invasion of the brain parenchyma from the bone marrow. It appears, as previously described , that local division regulates the microglia population at least in mice in pathogen-free laboratory conditions. Using BrdU labelling of dividing cells in animals in which the microglia are labelled with GFP driven from the colony-stimulating factor receptor-1 (CSFR1) promotor , there is indeed significant proliferation of the resident cells with some variation from one region of the brain to another . The turnover of the microglia is influenced by systemic events: microglia in the neurohypophysis proliferate during osmotic stress  and more generally following systemic challenge with lipopolysaccharide (LPS) . The increase in macrophages and microglia in the autoimmune disease experimental allergic encephalomyelitis (EAE) comes from both the proliferation of the microglia and invasion of monocytes .
One important message from the generation of BM-chimeras is that microglia morphology is not unique to yolk-sac-derived cells since some donor BM-derived cells can invade the parenchyma and develop morphology typical of microglia. This simple observation indicates that microglia morphology is a property largely imposed by the local microenvironment rather than their developmental origin. Deletion of microglia by another paradigm, using local cortical injection of ganciclovir to locally kill CD11b + microglia expressing HSV-thymidine kinase, led to re-population of the cortex by blood-derived monocytes within 2 weeks. While these cells developed morphological features of microglia, they were subtly distinct from the resident cells, and they had higher CD45 expression, even many months after invasion .
An important point to highlight is the marked species difference in the response to generation of BM-chimeras. The invasion of the irradiated CNS by grafted bone-marrow-derived cells may be a particular property of mice since the same experimental approach in rats, including irradiation of the brain, results in population of the perivascular space by BM-derived cells but not the brain parenchyma . Few studies have been carried out in larger animals, but in macaque monkey, the evidence suggests that transplanted adult CD34-positive stem cell progeny does not invade the parenchyma but only the perivascular space , and similarly, in humans with bone marrow transplants, BM-derived cells appear only to enter the perivascular space .
Perivascular and meningeal macrophages
In contrast to the microglia, the other populations of CNS macrophages have received much less attention with regard to their developmental origin and turnover. These macrophages have a distinct morphology and phenotype when compared to the microglia, illustrating the profound effect of the local microenvironment. The BM-chimera studies, be they in mouse with a head shield , rats or primates, show that perivascular macrophages are regularly replaced by cells recruited from the blood [23, 24]. The precise time period for replacement is not well described but usually reported as periods of months rather than days. The turnover of the macrophages in the circumventricular organs (CVOs) and choroid plexus has not been systematically studied. Recent studies have described the role of pericytes in the regulation of local blood flow and blood-brain barrier permeability, but their role in neuroinflammation and interactions with PVMs and microglia remains to be defined .
Cellular and solute drainage from the brain
An important question with regard to immune–brain communication is whether immune cells in the CNS can migrate from the CNS to lymphoid organs. The brain lacks a typical lymphatic drainage system, although interestingly, it is not known what components of the CNS microenvironment prevent the formation of lymphatic vessels. Despite the absence of lymphatics, there are well-described drainage routes for soluble molecules from the brain parenchyma along the perivascular space of the arteries into the cerebrospinal fluid and hence to the cervical lymph nodes in the neck . It is a contentious issue as to whether these routes might also be a lymphatic-like drainage route for PVMs and MMs to carry CNS or pathogen-derived antigens to cervical lymph nodes. In the normal healthy brain, it has been argued that the absence of dendritic cells in the brain parenchyma or perivascular space and the lack of migratory capacity of both microglia and PVMs account for the immune privilege of the CNS parenchyma  and permit bacterial and viral particles to persist in the parenchyma undetected by the immune system . By contrast, delivery of bacterial or viral particles to the ventricles or surface of the brain leads to a prompt immune response . This distinct compartmentalization of macrophage phenotypes may also be related to the very different responses of the parenchyma and meninges to challenge with agents such as lipopolysaccharide or cytokines that evoke stereotypic acute inflammatory responses in the meninges but not in the brain parenchyma .
Regulation of microglia phenotype
Under steady-state conditions, microglia display a striking down-regulated phenotype when compared with other CNS macrophages with low expression of CD45, Fc receptors and MHC class II. A recent study assessing gene expression in tissue macrophages from various mouse organs showed that all tissue macrophages express mRNA encoding diverse receptors such as the Mer tyrosine kinase receptor (MerTK), involved in phagocytosis of apoptotic cells, and mRNA encoding the toll-like receptors TLR4, TLR7, TLR8 and TLR13 involved in the recognition of microbial pathogen-derived molecules . Microglia in the normal healthy CNS display particularly low-level expression of hundreds of transcripts that are expressed in other macrophage populations, but enrichment of genes related to oxidative metabolism. This study not only extends the notion of the down-regulated phenotype of microglia under steady-state conditions, but also points to the role of microglia in homeostasis and first line of defence: they are well equipped to remove debris and apoptotic cells, respond to infectious and non-infectious danger signals and regulate oxidative processes.
The local microenvironment and, in particular, neurons and astrocytes play an integral role in regulating microglia phenotype via interaction with both soluble and membrane-bound mediators. Neurotropic factors released by neurons contribute to the down-regulated state of microglia and dampen inflammation in the CNS. For example, nerve growth factor inhibits MHC class II expression on microglia , and brain-derived neurotrophic factor down-regulates expression of co-stimulatory molecules B7 and CD40 . Microglia express diverse receptors for neurotransmitters , and neurotransmitters such as norepinephrine (NE) and γ-aminobutyric acid (GABA) have immune modulatory effects by suppressing pro-inflammatory cytokine production. For example, microglia and astrocytes, which are in intimate communication with microglia, express GABA(A) and GABA(B) receptors; activation of these receptors suppresses LPS or interferon-γ-mediated inflammation by inhibition of NFκB and P38 MAP kinase .
An important consequence of these interactions between neurons and microglia is that in conditions where neurons degenerate, either acutely or in chronic neurodegenerative disease, the microglia will be released from the tonic inhibition provided by neurons. There is also evidence that in animal models mimicking aspects of human neurodegenerative disease, the neuropathology may be enhanced by blockade of CD200–CD200R interactions  or deletion of CX3CR1 . Mutations in TREM-2 and CD33 have been associated with increased risk of Alzheimer’s disease, highlighting the importance of immune suppression, mediated by this class of immune receptors in maintenance of CNS homeostasis [44, 45, 46].
Microglia in the adult brain
Microglia are ubiquitously distributed in the adult CNS, but their distribution is not uniform. In the rodent brain, their density varies from regions with a high density, for example, the substantia nigra, to a low density, such as the molecular layer of the cerebellum; the fibre tracts also have a low density . The microglia each occupy their own territory, and in vivo imaging studies reveal that they continually palpate the neurons and glia within their territory such that they survey their ‘sphere of influence’ about every hour . The significance of the differential density distribution and the differences in morphology, the length and density of processes and local territory covered is largely a matter of conjecture, but it is not simply related to the extent of developmental cell death, the density of the vasculature or routes of entry into the CNS . The microglia express receptors for diverse neurotransmitters , but the distribution of microglia has not been readily related to any particular transmitter.
The regional differences in microglia density and morphology have led to investigations into possible functional differences in the adult naïve state, but expression of immune molecules such as CD80/CD86, CD11b, F4/80 and CXCR3 has only revealed subtle differences in young rodents ; the similarities are more striking than the differences. Recent evidence suggests that there is heterogeneity in the microglia response to a local inflammatory challenge, but whether this represents the response of distinct subgroups of microglia  or the stochastic nature of the transcriptional response  remains to be established. In the ageing CNS, the microglia show readily detectable regional differences, as discussed below.
CNS macrophages and microglia: the immune–brain interface
Although the phenotype and function of macrophages and microglia have predominantly focused on their role within the CNS and their very local interactions, it is known that these cells play an important role in communication between the systemic immune system and the brain. Systemic infection and inflammation lead to metabolic and behavioural changes that play an important role in protecting an organism and promoting recovery. The typical signs of a systemic infection lead to behaviours commonly referred to as “sickness behaviours” that include fever, malaise, lethargy, anorexia and depression . The routes by which systemic inflammation communicates with the brain include both neural and humoural pathways. Receptors for cytokines and other inflammatory mediators on afferent vagus nerve fibres respond to these molecules and signal to the nucleus of the solitary tract and hence to other regions of the CNS . Circulating cytokines and inflammatory mediators may communicate with macrophages in the circumventricular organs: regions of the CNS that lack a typical tight blood-brain barrier. Signals generated in the CVOs then communicate with neural signalling pathways in the brain . A further route of communication involves signalling from mediators in blood to the cerebral endothelial cells, which signal to the perivascular macrophages which, in turn, signal to the microglia. The signalling from the cerebral endothelium involves activation of COX-1 and COX-2 and the generation of prostaglandins and likely other mediators . The synthesis of cytokines such as interleukin-1β (IL-1) in the PVMs, microglia and cerebral endothelial cells has been demonstrated following systemic LPS challenge . Indeed, microinjection of IL-1 and other cytokines into the cerebral ventricles or local regions of the CNS can evoke sickness behaviours .
The signalling of systemic inflammation to the CNS, arising as a consequence of injury or disease, is part of normal homeostasis; it takes place across an intact blood-brain barrier and does not lead to damage of the neurons of the CNS. Although most of what we know about signalling from the peripheral immune system to the brain has been studied in rodents, experimental studies in humans provide evidence for similar effects of systemic inflammation. LPS challenge in humans leads to fever and neuropsychological symptoms. For example, low-dose endotoxin in healthy volunteers reduced declarative memory performance that was inversely correlated with cytokine increases  and increased symptoms of depression . Other clinical symptoms include fatigue and decrease in social interest. Similar findings have been described following influenza H1N1 virus infection; individuals reported symptoms of anxiety and depression up to 1 year after the infection . The use of biologicals as therapeutic agents has also provided valuable insight, and it is well known that peripheral injection of β-interferon leads to flu-like symptoms in patients with multiple sclerosis, that α-interferon therapy in patients with hepatitis C may lead to serious symptoms of depression in some individuals and that anti-tumour necrosis factor-α (anti-TNF) therapy in patients with psoriasis can lead to improvements in mood . There are likely multiple systemic inflammatory mediators that impact on innate immune cells in the CNS, leading to changes in behaviour.
The regulation of the microglia phenotype by the microenvironment of the CNS appears to be an important part of CNS immune physiology. The fact that these cells are derived from a particular developmental niche, are long lived, locally replaced and play a key role in signalling from the peripheral immune system to the brain, raises interesting questions on how disturbances of the CNS microenvironment such as neurodegeneration and ageing affect immune system to brain signalling. There is now a growing body of evidence to show that during neurodegeneration and normal ageing, the loss of the down-regulated phenotype of the microglia can have profound consequences for signalling from the immune system to brain: what was once an important part of homeostasis can become a maladaptive response.
Microglia priming in chronic neurodegeneration
The microglia are highly responsive to almost any form of injury or disease of the CNS and become activated. This activation is characterized by alterations in their morphology, such as hypertrophy of the cell soma, increased branching, upregulation or de novo synthesis of cell surface or intracellular molecules, and proliferation (Fig. 1b, d). Some of the most important diseases afflicting society today are the chronic neurodegenerative diseases of the CNS such as Alzheimer’s disease (AD), Parkinson’s disease, frontotemporal dementia and amyotrophic lateral sclerosis. Age is the single most important risk factor for the sporadic forms of these diseases, and with the demographic shift to longer lifespan, it is clear that the prevalence of these diseases will increase . The role of inflammation in disease progression is of much interest as manipulations of inflammation may help to ameliorate disease progression. There are many useful reviews on the possible roles of microglia in chronic neurodegeneration [63, 64], but we focus here on the concept of microglia priming and the impact of systemic inflammation.
Although there are numerous animal models that mimic aspects of AD, the deposition of amyloid and the accumulation of phosphorylated tau, these models are not models of chronic neurodegeneration. These models do not replicate the widespread and devastating loss of neurons in the AD brain: the loss of neurons is modest or absent. A tractable laboratory model of chronic neurodegeneration that involves the accumulation of a misfolded protein and is a fatal progressive neurodegenerative disease is murine prion disease. In this disease, microglia take on an activated morphology at discrete sites in the brain early in disease, and as the pathology spreads in a systematic fashion through the brain, the microglia take on an activated morphology . The stimulus that leads to this activation is not known but may include the loss of inhibitory contact with the neuronal ligands such as CD200, C3XCL1 described above, the accumulation of the misfolded protein, phagocytosis of apoptotic bodies and neuronal debris and other yet unidentified routes. Despite their apparent morphological activation, the microglia appear to have a predominantly anti-inflammatory phenotype.
Most tissue macrophages, following the appropriate stimulus, can polarize into M1 and M2 or M2-like phenotypes . Classical activation and M1 polarization require interferon-γ (IFN-γ) combined with TLR4 signalling and are characterized by increased expression of pro-inflammatory mediators and effectors enabling phagocytosis and killing of pathogens. Alternative activation and M2 polarization occur in response to IL-4 and are distinguished by increased expression of transforming growth factor-β (TGFβ), IL-10, scavenger receptor CD206, MS4A4a/6A and fibrinogenic and coagulation factors, enabling regulation of wound healing, tissue repair, collagen formation and recruitment of Th2 cells. ‘Regulatory’ macrophages with an M2-like phenotype share many characteristics with M1 macrophages, including expression of pro-inflammatory cytokines, but have an immunosuppressive function due to secretion of large amounts of IL‑10. These regulatory macrophages, or M2b macrophages, appear following Fc receptor ligation, have both pro- and anti-inflammatory function and recruit regulatory T cells. Finally, in response to IL-10, TGFβ, glucocorticoid or after ingestion of apoptotic cells, microglia polarize into deactivated or M2c cells, characterized by increased expression of scavenger receptor CD163 and CD206 and down-regulation of pro-inflammatory mediators. Microglia can exhibit different phenotypes that have some of the characteristics of M1- and M2-phenotypes, but they are also highly plastic cells and may transition between different states depending on both local and systemic influences.
The microglia in prion diseased brain, even early in the disease, are associated with high levels of TGFβ, prostaglandin-E2 (PGE2), colony-stimulating factor-1 (CSF1) and IL-34 [18, 67]. The microglia appear to have a relatively anti-inflammatory phenotype, which we have previously referred to as ‘benign’ with regard to driving disease progression [65, 68]. The microglia do not appear to be involved in the removal of the misfolded protein  nor in the removal of the degenerating synapses , although it is clear that they have phagocytic potential. Furthermore, a microarray analysis revealed upregulation of various genes which encode receptors of immune regulation (i.e. CD33, TREM-2, FcRs, Dectin-1) and down-stream ITIM signalling pathways . It has only recently became clear that this phenotype is not ‘benign’ since preventing microglia proliferation in the prion diseased animals using an inhibitor of the CSF1R kinase activity led to a delay in the onset of behavioural symptoms and prolonged their survival . The CSF1R kinase inhibitor not only reduced the numbers of microglia but also led to a further shift towards an M2-like phenotype with further upregulation of arginase-1 (ARG1) and YM1 mRNA .
The apparent anti-inflammatory or M2-like profile of the microglia in murine prion disease is in accord with that seen in some murine models of AD , where mice express human genes encoding for the AD-related proteins, but at odds with reports of pro-inflammatory cytokines in postmortem tissue from AD patients. To investigate how systemic inflammation, a common component of end-stage disease in AD patients, might impact on the microglia phenotype, we injected LPS into the peritoneum of mice with prion disease. These experiments showed that systemic inflammation can lead to a dramatic change in the phenotype of the microglia, which switch towards a pro-inflammatory phenotype with the expression of cytokines such as IL-1, IL-6 and TNF [73, 74]. We have also shown that systemic LPS challenge results in increased expression of a wide range of immune regulatory receptors that mediate their function via activating ITAM signalling, including IgG Fc receptors . The upregulation of FcRs was further investigated using prion-infected Fcγ-deficient mice, which failed to increase IL-1 expression in the CNS following systemic LPS challenge, despite a normal peripheral immune response. The systemic inflammation led to increased expression of serum-derived IgG in the brain parenchyma, suggesting a role for IgG-FcR interaction in switching primed microglia to an aggressive pro-inflammatory phenotype . A similar switch in microglia phenotype is seen with systemic challenge with the TLR3 agonists poly I:C to mimic a viral infection  and following intranasally administered live PR3 influenza (Teeling et al., unpublished observations). These changes in microglia phenotype are associated with an exaggeration of sickness behaviours, such as fever, loss of activity, loss of burrowing behaviour and an acceleration of disease progression with earlier onset of cognitive impairments and motor deficits [74, 76]. We proposed that the microglia are ‘primed’ by the ongoing neurodegeneration and that the systemic mediators signalling across the blood-brain barrier lead to a switch in microglia phenotype.
The concept of macrophage priming is well known in the context of in vitro systems with priming of macrophages by IFN-γ prior to a challenge with a TLR agonist. Cross regulation of innate immune receptors such as TLR and IFN-γ receptors that activate PI3K and/or NFkB may explain this enhanced response to the TLR agonist . Although in the prion diseased brain there are small numbers of T-cells recruited to sites of pathology , these cells do not synthesize detectable amounts of IFN-γ, and indeed, they appear to be anergic (Teeling et al., unpublished observations). Further insight into macrophage priming has come from in vitro cultures of macrophages with high and low concentrations of LPS. Low-dose LPS (5–50 pg/ml) failed to induce PI3K and NFkB and instead utilized IRAK-1 to induce mitochondrial ROS, which, in turn, allows the transcription factor ATF2 to bind DNA, resulting in low-grade but prolonged expression of pro-inflammatory cytokines [79, 80]. Other possible candidates for priming the microglia in the absence of IFN-γ are the cytokines CSF1 and IL-34, which both signal through CSFR1. In vitro and in vivo mouse studies show that pre-exposure to CSF1 can lead to increased synthesis of cytokines IL-6 and TNF to a subsequent LPS challenge .
The data thus suggest that the normal homeostatic signalling from the peripheral immune system to brain is distorted in the diseased brain and leads to the generation of a response in the brain that can increase disease symptoms, increase neuronal loss and accelerate disease progression. The primed microglia now produce a maladaptive response during systemic inflammation.
Evidence for this microglia priming phenomenon has now been described in a number of different animal models of neurodegeneration with a similar switch in the cytokine profile following systemic challenges. APP transgenic mice challenged with LPS synthesized increased pro-inflammatory cytokines in the CNS . Degeneration of cells in the substantia nigra (SN) can be induced with a number of different protocols to generate a model of Parkinson’s disease, and subsequent systemic challenge of animals with IL-1 leads to enhanced degeneration of SN neurons and pro-inflammatory cytokine production . It has long been known that systemic infection is associated with relapses in multiple sclerosis, and there is evidence to suggest that relapses precipitated by an infection may have long-term consequences on clinical disease . In the animal model of multiple sclerosis, EAE, systemic challenge with LPS or other bacterial toxins can exacerbate neurological symptoms . Even in the absence of clinical symptoms following a systemic challenge, there is increased axon injury associated with inducible nitric oxide synthase (iNOS) induction in microglia . There was, however, significant heterogeneity in the appearance of the lesions after LPS challenge, with pronounced induction of axon injury in some and minimal axon injury in others. Laser dissection of individual lesions and further characterization showed that lesions with ongoing axon injury were associated with pro-inflammatory cytokine mRNA profile and iNOS synthesis, while the lesions with no or limited axon injury were dominated by the cytokine IL-10 . These data show that the local regulation by the CNS microenvironment plays an important role in response to the systemic challenge.
Microglia priming and ageing
It is well known that ageing is characterized by a decline in the function of the adaptive immune system, resulting in increased antigenic stress, increased oxidative stress and increased incidence of autoimmunity. The innate immune system remains intact and functional, and the reduced activity of the adaptive immune system results in a low-grade chronic pro-inflammatory state, so called inflamm-ageing . This increased pro-inflammatory peripheral tissue environment may impact on the brain by activation of cerebral endothelial cells as well as on innate immune cells in the CNS. We, and others, have shown that microglia in the rodent brain take on an activated phenotype during ageing, characterized by increased expression of CD11b, CD68, F4/80, FcRI and CD11c . Although microglia adopt this activated phenotype, pro-inflammatory cytokines are generally not increased above baseline levels. The phenotype and morphological changes in microglia are region specific, with caudal regions such as the cerebellum more affected than rostral forebrain regions. Microglia in white matter showed significant increased expression of CD11c and FcRI relative to microglia in grey matter.
The change in cell surface antigen repertoire seen in the aged brain is also associated with a primed microglia phenotype: challenge of aged rodents with systemic LPS leads to exaggerated sickness behaviours and enhanced cytokine synthesis of IL-1 and IL-10, and increased expression of TLR2, MHCII and indoleamine 2,3-dioxygenase (IDO) mRNA, and the latter is associated with depressive-like behaviours [89, 90]. The primed phenotype of microglia may be a consequence of the loss of molecules, both soluble and cell-bound mediators, involved in maintaining the down-regulated phenotype and may also reflect changes in the responsiveness of the microglia to inhibitory molecules such as IL-10 .
The priming of microglia in the ageing brain is of particular importance as one of the components by which systemic inflammation, associated with infection, trauma or drug insult, in elderly individuals with no apparent brain disease, may lead to delirium. Delirium is a condition in which a patient shows a neuropsychiatric episode typified by fluctuating degree of disorientation, confusion, memory loss and disturbances of attention. The pathology underlying delirium is not well understood, but the exaggerated sickness behaviours precipitated by systemic inflammation signalling across an intact blood-brain barrier to primed microglia suggest cellular and molecular pathways that may underpin delirium [91, 92]. Even in the absence of delirium, low-level systemic inflammation and infections are associated with more rapid cognitive decline in AD patients .
Peripheral routes to microglia priming
Local changes in soluble and cell mediators expressed by neurons and astrocytes are one potential route by which microglia priming arises and the cells escape from the inhibitory CNS microenvironment. Since transient systemic inflammation, such as that induced by a peripheral LPS or poly I:C challenge, can affect microglia, it is of interest to consider whether the environment in which animals are raised also plays a role. Rats raised and maintained in a conventional animal house showed a robust immune response in the brain parenchyma following the microinjection of an adenoviral vector engineered to express beta-galactosidase. In contrast, animals raised in a specific pathogen-free unit show a much reduced inflammatory response to the virus and prolonged expression of the beta-galactosidase gene . More recently, we have shown that peripheral challenge with Salmonella typhimurium leads to activation of the cerebral endothelium and microglia . To investigate whether the microglia in the brain parenchyma were primed by the systemic inflammation, we microinjected a very small amount of LPS into the brain parenchyma, which, in normal animals, evoked little or no inflammatory response. In animals previously challenged with S. typhimurium, there was a more robust inflammatory response at the site of the LPS injection. The priming of the innate immune response in the CNS is associated with ageing, neurodegeneration and systemic inflammation.
Experimental and clinical studies have each provided evidence for a detrimental role of microglia in age-related CNS disorders, but the biological factors that initiate innate immune activation in the CNS are still elusive. Normal ageing is associated with loss of synapses, changes in the integrity of the fibre tracts and increases in oxidative stress, and it is likely that all these changes affect microglial function, due to altered neuroglial interactions. A heightened innate immune response has been referred to as inflamm-aging, an adaptive response to aid re-establishment of homeostasis. This process is under tight control, and when it fails, chronic inflammation occurs, which may contribute to tissue damage and disease progression.
Work in the authors’ laboratory is supported by funding from the MRC (UK), the Wellcome Trust, Fight for Sight, ARUK and the EU.
- 5.Hume DA, Perry VH, Gordon S (1983) Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol 97(1):253–257PubMedCrossRefGoogle Scholar
- 40.Angata T, Kerr SC, Greaves DR, Varki NM, Crocker PR et al (2002) Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J Biol Chem 277(27):24466–24474PubMedCrossRefGoogle Scholar
- 59.Dellagioia N, Devine L, Pittman B, Hannestad J (2012) Bupropion pre-treatment of endotoxin-induced depressive symptoms. Brain Behav Immun. doi: 10.1016/j.bbi.2012.10.008.
- 89.Henry CJ, Huang Y, Wynne AM, Godbout JP (2009) Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun 23:309–317PubMedCrossRefGoogle Scholar
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.